Composition
Sitagliptin Tablets
Interested in this product?
Contact us for export pricing, bulk orders, and regulatory documentation.
Request QuoteProduct Overview
Sitaberg contains Sitagliptin, a highly selective DPP-4 inhibitor that improves glycaemic control by increasing active incretin hormone levels.
Indication
Type 2 diabetes mellitus as monotherapy or in combination with Metformin, sulfonylureas, or insulin.
Packaging
10 x 10 Alu-Alu strip pack
Storage
Store below 25°C, protected from light.
Export Ready
Available for export with full regulatory documentation, COA, and dossier support for international registration.
Disclaimer: This product information is intended for healthcare professionals and authorized distributors only. It is not intended as medical advice. Please refer to the full prescribing information for complete details. Regulatory approvals may vary by country.